EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer. (2019)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers11081067
PubMed Identifier: 31357743
Publication URI: http://europepmc.org/abstract/MED/31357743
Type: Journal Article/Review
Volume: 11
Parent Publication: Cancers
Issue: 8
ISSN: 2072-6694